Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 135, Issue 9, Pages 2206-2214
Publisher
Wiley
Online
2014-03-19
DOI
10.1002/ijc.28857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer
- (2013) Miriam Lohr et al. CANCER LETTERS
- Tight junction proteins: From barrier to tumorigenesis
- (2013) E. Aaron Runkle et al. CANCER LETTERS
- Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms
- (2013) Stefan Wöll et al. INTERNATIONAL JOURNAL OF CANCER
- The receptor tyrosine kinase Axl in cancer: Biological functions and therapeutic implications
- (2013) Juliano D. Paccez et al. INTERNATIONAL JOURNAL OF CANCER
- The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer
- (2013) Michael Thornton et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease
- (2013) Kadoaki Ohashi et al. JOURNAL OF CLINICAL ONCOLOGY
- A Patient with Lung Adenocarcinoma and RET Fusion Treated with Vandetanib
- (2013) Oliver Gautschi et al. Journal of Thoracic Oncology
- Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells
- (2013) Uri Ben-David et al. Nature Communications
- Roles for claudins in alveolar epithelial barrier function
- (2012) Christian E. Overgaard et al. Annals of the New York Academy of Sciences
- Claudin Heterogeneity and Control of Lung Tight Junctions
- (2012) Michael Koval Annual Review of Physiology
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- (2012) Marcin Imielinski et al. CELL
- Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- (2012) J. Botling et al. CLINICAL CANCER RESEARCH
- Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas
- (2012) Tetsuo Ushiku et al. HISTOPATHOLOGY
- CD99 is a novel prognostic stromal marker in non-small cell lung cancer
- (2012) Karolina Edlund et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation
- (2012) Y Soini et al. JOURNAL OF CLINICAL PATHOLOGY
- Targeting ALK, ROS1, and BRAF Kinases
- (2012) Robert C. Doebele et al. Journal of Thoracic Oncology
- Targeted Therapies for Lung Cancer
- (2011) Jill E. Larsen et al. CANCER JOURNAL
- Predicted expansion of the claudin multigene family
- (2011) Katsuhiko Mineta et al. FEBS LETTERS
- Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals
- (2011) Özlem Türeci et al. GENE
- Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis
- (2011) Mariko Tanaka et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Novel Therapeutic Targets in Non-small Cell Lung Cancer
- (2011) Filip Janku et al. Journal of Thoracic Oncology
- Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer
- (2011) Patrick Micke et al. Journal of Thoracic Oncology
- Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma
- (2011) Aya Shinozaki et al. VIRCHOWS ARCHIV
- Keratinocyte growth factor enhances barrier function without altering claudin expression in primary alveolar epithelial cells
- (2010) Michael J. LaFemina et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Claudin-6, 7, or 9 Overexpression in the Human Gastric Adenocarcinoma Cell Line AGS Increases Its Invasiveness, Migration, and Proliferation Rate
- (2010) Veronica Elizabeth Zavala-Zendejas et al. CANCER INVESTIGATION
- Claudins: unlocking the code to tight junction function during embryogenesis and in disease
- (2010) IR Gupta et al. CLINICAL GENETICS
- Immunohistochemical analysis of colorectal cancer with gastric phenotype: Claudin-18 is associated with poor prognosis
- (2010) Miho Matsuda et al. PATHOLOGY INTERNATIONAL
- Immunohistochemical Staining of Reg IV and Claudin-18 is Useful in the Diagnosis of Gastrointestinal Signet Ring Cell Carcinoma
- (2009) Kazuhiro Sentani et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8
- (2009) Zarir E. Karanjawala et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Diagnostic utility of expression of claudins in non-small cell lung cancer: Different expression profiles in squamous cell carcinomas and adenocarcinomas
- (2009) Ji Han Jung et al. PATHOLOGY RESEARCH AND PRACTICE
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
- (2008) U. Sahin et al. CLINICAL CANCER RESEARCH
- Structure and function of claudins
- (2007) Gerd Krause et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started